These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26759404)

  • 21. A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.
    Yazici Y; Erkan D; Lockshin MD
    Clin Exp Rheumatol; 2000; 18(6):732-4. PubMed ID: 11138337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
    Kitamura G; Mehr N; Anderson N; Sirichotiratana M
    Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.
    Hamilton TK
    J Drugs Dermatol; 2008 Nov; 7(11):1089-93. PubMed ID: 19110745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
    Constantin T; Foeldvari I; Vojinovic J; Horneff G; Burgos-Vargas R; Nikishina I; Akikusa JD; Avcin T; Chaitow J; Koskova E; Lauwerys BR; Calvo Penades I; Flato B; Gamir ML; Huppertz HI; Jaller Raad JJ; Jarosova K; Anton J; Macku M; Otero Escalante WJ; Rutkowska-Sak L; Trauzeddel R; Velez-Sanchez PJ; Wouters C; Wajdula J; Zang C; Bukowski J; Woodworth D; Vlahos B; Martini A; Ruperto N;
    J Rheumatol; 2016 Apr; 43(4):816-24. PubMed ID: 26932344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A further patient with parasitic myositis due to Haycocknema perplexum, a rare entity.
    McKelvie P; Reardon K; Bond K; Spratt DM; Gangell A; Zochling J; Daffy J
    J Clin Neurosci; 2013 Jul; 20(7):1019-22. PubMed ID: 23664131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 27. Idiopathic inflammatory myopathies-a review.
    Jones J; Wortmann R
    Clin Rheumatol; 2015 May; 34(5):839-44. PubMed ID: 25681070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis.
    Turashvili G; Farmer P
    J Dermatolog Treat; 2015 Apr; 26(2):124-7. PubMed ID: 24646144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of mesangial immunoglobulin IgA glomerulonephritis and p-ANCA positivity in a patient with psoriatic arthritis].
    Nazzaro P; Battaglia R; D'Altri C; Marangi AL; Perniola M; Rodio A; De Padova F
    G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myositis in primary Sjögren's syndrome: data from a multicentre cohort.
    Colafrancesco S; Priori R; Gattamelata A; Picarelli G; Minniti A; Brancatisano F; D'Amati G; Giordano C; Cerbelli B; Maset M; Quartuccio L; Bartoloni E; Carubbi F; Cipriani P; Baldini C; Luciano N; De Vita S; Gerli R; Giacomelli R; Bombardieri S; Valesini G
    Clin Exp Rheumatol; 2015; 33(4):457-64. PubMed ID: 26088683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
    Mease PJ; Kivitz AJ; Burch FX; Siegel EL; Cohen SB; Ory P; Salonen D; Rubenstein J; Sharp JT; Dunn M; Tsuji W
    J Rheumatol; 2006 Apr; 33(4):712-21. PubMed ID: 16463435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.
    Gniadecki R; Robertson D; Molta CT; Freundlich B; Pedersen R; Li W; Boggs R; Zbrozek AS
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1436-43. PubMed ID: 22035157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
    Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial.
    Gladman DD; Bombardier C; Thorne C; Haraoui B; Khraishi M; Rahman P; Bensen W; Syrotuik J; Poulin-Costello M
    J Rheumatol; 2011 Jul; 38(7):1355-62. PubMed ID: 21572156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myositis in the presence of slightly elevated creatine kinase values].
    van Vonderen MG; ter Maaten JC; van der Valk P; Hoorntje SJ; Gans RO
    Ned Tijdschr Geneeskd; 1999 May; 143(18):949-53. PubMed ID: 10368712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE; Clarke S
    J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis.
    Murdaca G; Negrini S; Magnani O; Penza E; Pellecchio M; Puppo F
    Expert Opin Drug Saf; 2017 Oct; 16(10):1173-1179. PubMed ID: 28750567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature.
    Mourão AF; Rustin M; Isenberg D
    Clin Exp Rheumatol; 2010; 28(3):408-10. PubMed ID: 20576227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.